A systematic review recently reported that antidepressants were beneficial for GERD patients " curbing esophageal sensation and reducing functional chest pain.
Amy Jacob, HCPLive
Advertisement
Articles by Amy Jacob, HCPLive
The FDA has approved a new indication for adalimumab (Humira) to treat pediatric patients age 6 years and older afflicted with moderately to severely active Crohn's disease.
Advertisement
Latest Updated Articles
- FDA Approves Humira for the Treatment of Crohn's Disease in Children
September 25th 2014
- Does Treatment with Antidepressants Benefit Esophageal Disorders?
January 29th 2015
Advertisement
Advertisement
Trending on Pharmacy Times
1
Elevating Precision Medicine in Breast Cancer Care
2
FDA Clears First Single-Inhaler Triple Therapy for Asthma
3
FDA Approves Capvaxive Expanded Indication to Include Children, Adolescents at Increased Risk for Pneumococcal Disease
4
Sonrotoclax Plus Zanubrutinib Achieves Undetectable MRD Rates Above 90% in Frontline CLL/SLL
5